Skip to main content
Top
Published in: Malaria Journal 1/2018

Open Access 01-12-2018 | Research

Scaling up malaria intervention “packages” in Senegal: using cost effectiveness data for improving allocative efficiency and programmatic decision-making

Authors: Sophie Faye, Altea Cico, Alioune Badara Gueye, Elaine Baruwa, Benjamin Johns, Médoune Ndiop, Martin Alilio

Published in: Malaria Journal | Issue 1/2018

Login to get access

Abstract

Background

Senegal’s National Malaria Control Programme (NMCP) implements control interventions in the form of targeted packages: (1) scale-up for impact (SUFI), which includes bed nets, intermittent preventive treatment in pregnancy, rapid diagnostic tests, and artemisinin combination therapy; (2) SUFI + reactive case investigation (focal test and treat); (3) SUFI + indoor residual spraying (IRS); (4) SUFI + seasonal malaria chemoprophylaxis (SMC); and, (5) SUFI + SMC + IRS. This study estimates the cost effectiveness of each of these packages to provide the NMCP with data for improving allocative efficiency and programmatic decision-making.

Methods

This study is a retrospective analysis for the period 2013–2014 covering all 76 Senegal districts. The yearly implementation cost for each intervention was estimated and the information was aggregated into a package cost for all covered districts. The change in the burden of malaria associated with each package was estimated using the number of disability adjusted life-years (DALYs) averted. The cost effectiveness (cost per DALY averted) was then calculated for each package.

Results

The cost per DALY averted ranged from $76 to $1591 across packages. Using World Health Organization standards, 4 of the 5 packages were “very cost effective” (less than Senegal’s GDP per capita). Relative to the 2 other packages implemented in malaria control districts, the SUFI + SMC package was the most cost-effective package at $76 per DALY averted. SMC seems to make IRS more cost effective: $582 per DALY averted for SUFI + IRS compared with $272 for the SUFI + IRS + SMC package. The SUFI + focal test and treat, implemented in malaria elimination districts, had a cost per DALY averted of $1591 and was only “cost-effective” (less than three times Senegal’s per capita GDP).

Conclusion

Senegal’s choice of deploying malaria interventions by packages seems to be effectively targeting high burden areas with a wide range of interventions. However, not all districts showed the same level of performance, indicating that efficiency gains are still possible.
Footnotes
1
At least 60% of cases occur within 4 months of the year, including at least 10% annual incidence among children.
 
2
The district is the smallest administrative subdivision in the Senegalese health system.
 
3
TRMM 3B43 data contain the best-estimate precipitation rate (in mm/h) and root-mean-square (RMS) precipitation-error estimates from TRMM and other data sources.
 
4
Distribution costs refer to all logistic costs related to distributing the intervention: transport, communication, material, equipment (depreciated if applicable), and other logistics costs. Interventions implemented through the health system do not have separate distribution costs (case management, IPTp).
 
5
Consumable costs refer to the cost of tests and drugs for case management, PECADOM, IPTp, RCI, SMC; cost of nets for LLIN distribution; cost of insecticides for IRS.
 
7
From 2010 to 2012, Senegal’s health workers were on strike, using data retention as a means of protest. Normal routine data collection resumed in 2013.
 
Literature
1.
go back to reference WHO. World malaria report 2016. Geneva: World Health Organization; 2016. WHO. World malaria report 2016. Geneva: World Health Organization; 2016.
2.
3.
go back to reference Gunda R, Chimbari MJ. Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review. Cost Eff Resour Alloc. 2017;15:10.CrossRefPubMedPubMedCentral Gunda R, Chimbari MJ. Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review. Cost Eff Resour Alloc. 2017;15:10.CrossRefPubMedPubMedCentral
4.
go back to reference Goodman CA, Mills AJ. The evidence base on the cost-effectiveness of malaria control measures in Africa. Health Policy Plan. 1999;14:301–12.CrossRefPubMed Goodman CA, Mills AJ. The evidence base on the cost-effectiveness of malaria control measures in Africa. Health Policy Plan. 1999;14:301–12.CrossRefPubMed
5.
go back to reference Morel CM, Lauer JA, Evans DB. Achieving the millennium development goals for health—cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ. 2005;331:1299.CrossRefPubMedPubMedCentral Morel CM, Lauer JA, Evans DB. Achieving the millennium development goals for health—cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ. 2005;331:1299.CrossRefPubMedPubMedCentral
6.
go back to reference Stuckey EM, Stevenson J, Galactionova K, Baidjoe AY, Bousema T, Odongo W, et al. Modeling the cost effectiveness of malaria control interventions in the highlands of Western Kenya. PLoS ONE. 2014;9:e107700.CrossRefPubMedPubMedCentral Stuckey EM, Stevenson J, Galactionova K, Baidjoe AY, Bousema T, Odongo W, et al. Modeling the cost effectiveness of malaria control interventions in the highlands of Western Kenya. PLoS ONE. 2014;9:e107700.CrossRefPubMedPubMedCentral
10.
go back to reference Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of healthcare programmes. 3rd ed. Oxford: Oxford University Press; 2005. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of healthcare programmes. 3rd ed. Oxford: Oxford University Press; 2005.
11.
go back to reference Sun DW, Du JW, Wang GZ, Li YC, He CH, Xue RD, et al. A cost-effectiveness analysis of Plasmodium falciparum malaria elimination in Hainan Province, 2002–2012. Am J Trop Med Hyg. 2015;93:1240–8.CrossRefPubMedPubMedCentral Sun DW, Du JW, Wang GZ, Li YC, He CH, Xue RD, et al. A cost-effectiveness analysis of Plasmodium falciparum malaria elimination in Hainan Province, 2002–2012. Am J Trop Med Hyg. 2015;93:1240–8.CrossRefPubMedPubMedCentral
12.
go back to reference Fox-Rushby JA, Hanson K. Calculating and presenting DALY in cost effectiveness analysis. Health Policy Plan. 2001;16:326–31.CrossRefPubMed Fox-Rushby JA, Hanson K. Calculating and presenting DALY in cost effectiveness analysis. Health Policy Plan. 2001;16:326–31.CrossRefPubMed
13.
go back to reference Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C. Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med. 2011;8:e1001142.CrossRefPubMedPubMedCentral Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C. Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med. 2011;8:e1001142.CrossRefPubMedPubMedCentral
14.
go back to reference WHO. World malaria report 2011. Geneva: World Health Organization; 2011. WHO. World malaria report 2011. Geneva: World Health Organization; 2011.
17.
go back to reference Gunda R, Chimbari MJ, Mukaratirwa S. Assessment of burden of malaria in Gwanda District, Zimbabwe, using the disability adjusted life years. Int J Environ Res Public Health. 2016;13:244.CrossRefPubMedPubMedCentral Gunda R, Chimbari MJ, Mukaratirwa S. Assessment of burden of malaria in Gwanda District, Zimbabwe, using the disability adjusted life years. Int J Environ Res Public Health. 2016;13:244.CrossRefPubMedPubMedCentral
18.
go back to reference WHO. Investing in health research and development: report of the ad hoc committee on health research relating to future intervention options. Geneva: World Health Organization; 1996. WHO. Investing in health research and development: report of the ad hoc committee on health research relating to future intervention options. Geneva: World Health Organization; 1996.
19.
go back to reference Mueller DH, Abeku TA, Okia M, Rapuoda B, Cox J. Costs of early detection systems for epidemic malaria in highland areas of Kenya and Uganda. Malar J. 2009;8:17.CrossRefPubMedPubMedCentral Mueller DH, Abeku TA, Okia M, Rapuoda B, Cox J. Costs of early detection systems for epidemic malaria in highland areas of Kenya and Uganda. Malar J. 2009;8:17.CrossRefPubMedPubMedCentral
21.
go back to reference Dohyeong K, Fedak K, Kramer R. Reduction of malaria prevalence by indoor residual spraying: a meta-regression analysis. Am J Trop Med Hyg. 2012;87:117–24.CrossRef Dohyeong K, Fedak K, Kramer R. Reduction of malaria prevalence by indoor residual spraying: a meta-regression analysis. Am J Trop Med Hyg. 2012;87:117–24.CrossRef
22.
go back to reference Katureebe A, Zinszer K, Arinaitwe E, Rek J, Kakande E, Charland K, et al. Measures of malaria burden after long-lasting insecticidal net distribution and indoor residual spraying at three sites in Uganda: a prospective observational study. PLoS Med. 2016;13:e1002167.CrossRefPubMedPubMedCentral Katureebe A, Zinszer K, Arinaitwe E, Rek J, Kakande E, Charland K, et al. Measures of malaria burden after long-lasting insecticidal net distribution and indoor residual spraying at three sites in Uganda: a prospective observational study. PLoS Med. 2016;13:e1002167.CrossRefPubMedPubMedCentral
23.
go back to reference West PA, Protopopoff N, Wright A, Kivaju Z, Tigererwa R, Mosha FW, et al. Indoor residual spraying in combination with insecticide-treated nets alone compared to insecticide-treated nets alone for protection against malaria: a cluster randomized trial in Tanzania. PLoS Med. 2014;11:e1001630.CrossRefPubMedPubMedCentral West PA, Protopopoff N, Wright A, Kivaju Z, Tigererwa R, Mosha FW, et al. Indoor residual spraying in combination with insecticide-treated nets alone compared to insecticide-treated nets alone for protection against malaria: a cluster randomized trial in Tanzania. PLoS Med. 2014;11:e1001630.CrossRefPubMedPubMedCentral
24.
go back to reference Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;2:CD000363. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;2:CD000363.
25.
go back to reference Kouznetsov RL. Malaria control by application of indoor spraying of residual insecticides in tropical Africa and its impact on community health. Trop Doct. 1977;7:81–91.CrossRefPubMed Kouznetsov RL. Malaria control by application of indoor spraying of residual insecticides in tropical Africa and its impact on community health. Trop Doct. 1977;7:81–91.CrossRefPubMed
27.
go back to reference Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, Khatib R, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 2007;4:1784–90.CrossRef Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, Khatib R, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 2007;4:1784–90.CrossRef
28.
go back to reference Kleinschmidt I, Schwabe C, Benavente L, Torrez M, Ridl FC, Segura JL, et al. Marked increase in child survival after four years of intensive malaria control. Am J Trop Med Hyg. 2009;80:882–8.PubMedPubMedCentral Kleinschmidt I, Schwabe C, Benavente L, Torrez M, Ridl FC, Segura JL, et al. Marked increase in child survival after four years of intensive malaria control. Am J Trop Med Hyg. 2009;80:882–8.PubMedPubMedCentral
29.
go back to reference Roll Back Malaria Partnership. The global malaria action plan for a malaria-free world. Geneva: Switzerland; 2008. Roll Back Malaria Partnership. The global malaria action plan for a malaria-free world. Geneva: Switzerland; 2008.
31.
32.
33.
go back to reference Gonzalez-Silva M, Bassat Q, Alonso PL. Getting ready for malaria elimination: a check list of critical issues to consider. Mem Inst Oswaldo Cruz. 2014;109:517–21.CrossRefPubMedPubMedCentral Gonzalez-Silva M, Bassat Q, Alonso PL. Getting ready for malaria elimination: a check list of critical issues to consider. Mem Inst Oswaldo Cruz. 2014;109:517–21.CrossRefPubMedPubMedCentral
Metadata
Title
Scaling up malaria intervention “packages” in Senegal: using cost effectiveness data for improving allocative efficiency and programmatic decision-making
Authors
Sophie Faye
Altea Cico
Alioune Badara Gueye
Elaine Baruwa
Benjamin Johns
Médoune Ndiop
Martin Alilio
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2018
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-018-2305-6

Other articles of this Issue 1/2018

Malaria Journal 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.